FDA Inspection 1290528 — TWi Pharmaceuticals Inc.
The FDA completed an inspection of TWi Pharmaceuticals Inc. on Mar 27, 2026 in Taipei City. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 27, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Taipei City (Taiwan)
Additional Details
Postmarket Adverse Drug Experience (PADE)